Literature DB >> 19480574

High frequency of antiretroviral drug resistance among HIV-infected adults receiving first-line highly active antiretroviral therapy in N'Djamena, Chad.

Donato Koyalta1, Charlotte Charpentier, Jatibi Beassamda, Elisabeth Rey, Ali Si-Mohamed, Noël Djemadji-Oudjeil, Laurent Bélec.   

Abstract

Antiretroviral drug resistance was evaluated in 88 adults infected with human immunodeficiency virus, most with subtype CRF11_cpx, who had received a first-line antiretroviral regimen for 6 months, in N'Djamena, Chad. A total of 47 patients (53%) had detectable viral load at month 6, and 56 (64%) had at least 1 antiretroviral resistance mutation observed.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19480574     DOI： 10.1086/599611

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  14 in total

1.  A retrospective survey of HIV drug resistance among patients 1 year after initiation of antiretroviral therapy at 4 clinics in Malawi.

Authors:  Nellie Wadonda-Kabondo; Bethany L Hedt; Joep J van Oosterhout; Kundai Moyo; Eddie Limbambala; George Bello; Ben Chilima; Erik Schouten; Anthony Harries; Moses Massaquoi; Carol Porter; Ralf Weigel; Mina Hosseinipour; John Aberle-Grasse; Michael R Jordan; Storn Kabuluzi; Diane E Bennett
Journal:  Clin Infect Dis       Date:  2012-05       Impact factor: 9.079

Review 2.  TB and HIV in the Central African region: current knowledge and knowledge gaps.

Authors:  S Janssen; M A M Huson; S Bélard; S Stolp; N Kapata; M Bates; M van Vugt; M P Grobusch
Journal:  Infection       Date:  2013-12-06       Impact factor: 3.553

3.  Prevalence of HIV drug resistance before and 1 year after treatment initiation in 4 sites in the Malawi antiretroviral treatment program.

Authors:  Nellie Wadonda-Kabondo; Diane Bennett; Joep J van Oosterhout; Kundai Moyo; Mina Hosseinipour; Josh Devos; Zhiyong Zhou; John Aberle-Grasse; Thomas R Warne; Clement Mtika; Ben Chilima; Richard Banda; Olesi Pasulani; Carol Porter; Sam Phiri; Andreas Jahn; Debbie Kamwendo; Michael R Jordan; Storn Kabuluzi; Frank Chimbwandira; Mathew Kagoli; Blackson Matatiyo; Austin Demby; Chunfu Yang
Journal:  Clin Infect Dis       Date:  2012-05       Impact factor: 9.079

4.  Cost-effectiveness of tenofovir instead of zidovudine for use in first-line antiretroviral therapy in settings without virological monitoring.

Authors:  Viktor von Wyl; Valentina Cambiano; Michael R Jordan; Silvia Bertagnolio; Alec Miners; Deenan Pillay; Jens Lundgren; Andrew N Phillips
Journal:  PLoS One       Date:  2012-08-08       Impact factor: 3.240

5.  Trends in prevalence of HIV-1 drug resistance in Thailand 2009-2010.

Authors:  Sayompoo Sanguansittianant; Nattakarn Nooroon; Poonlaph Phaengchomduan; Palanee Ammaranond
Journal:  J Clin Lab Anal       Date:  2013-09       Impact factor: 2.352

6.  Dried blood spots for viral load monitoring in Malawi: feasible and effective.

Authors:  Sarah E Rutstein; Mina C Hosseinipour; Deborah Kamwendo; Alice Soko; Memory Mkandawire; Andrea K Biddle; William C Miller; Morris Weinberger; Stephanie B Wheeler; Abdoulaye Sarr; Sundeep Gupta; Frank Chimbwandira; Reuben Mwenda; Steve Kamiza; Irving Hoffman; Ronald Mataya
Journal:  PLoS One       Date:  2015-04-21       Impact factor: 3.240

7.  Low Incidence of HIV-1C Acquired Drug Resistance 10 Years after Roll-Out of Antiretroviral Therapy in Ethiopia: A Prospective Cohort Study.

Authors:  Andargachew Mulu; Melanie Maier; Uwe Gerd Liebert
Journal:  PLoS One       Date:  2015-10-29       Impact factor: 3.240

8.  Field evaluation in Chad of community usage of CD4 T lymphocyte counting by alternative single-platform flow cytometry.

Authors:  Donato Koyalta; Mohammad-Ali Jenabian; Barou Djouater; Noël Djemadji-Oudjeil; Francois-Xavier Mbopi-Keou; Angélique Ndjoyi-Mbiguino; Laurent Bélec
Journal:  BMC Health Serv Res       Date:  2013-10-01       Impact factor: 2.655

9.  Spatiotemporal dynamics of the HIV-1 subtype G epidemic in West and Central Africa.

Authors:  Edson Delatorre; Daiana Mir; Gonzalo Bello
Journal:  PLoS One       Date:  2014-06-11       Impact factor: 3.240

10.  A putative HIV-1 subtype C/CRF11_cpx unique recombinant from South Africa.

Authors:  Pascal Obong Bessong; Benson Iweriebor
Journal:  Springerplus       Date:  2016-03-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.